71 results
8-K
EX-10.1
COGT
Cogent Biosciences Inc
22 Mar 24
Unregistered Sales of Equity Securities
8:33am
, assessment, arbitration or inquiry, or any proceeding or, to the Stockholder’s knowledge, investigation, by or before any governmental authority
8-K
EX-10.2
3be2d09nu rsm
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
424B5
hvf rlrxy9yr
8 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
g92nbjt
6 Jun 23
Prospectus supplement for primary offering
5:22pm
8-K
EX-99.2
6jqi9u81 dox
12 Dec 22
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating
8:03am
8-K
EX-99.1
bpeh3ct
12 Dec 22
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating
8:03am
8-K
EX-99.1
bu0p2wn1sryx9z 1px
14 Nov 22
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results
7:14am
424B5
eqk5f14ff0
15 Jun 22
Prospectus supplement for primary offering
5:16pm
424B5
fkipso4j
13 Jun 22
Prospectus supplement for primary offering
6:11am
8-K
EX-99.1
4uffaav84
10 Jun 22
Submission of Matters to a Vote of Security Holders
7:12am